Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)

Market Cap	8.11B
Revenue (ttm)	2.94B
Net Income (ttm)	-1.35B
Shares Out	995.27M
EPS (ttm)	-1.34
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	166,922,503
Average Volume	106,257,650
Open	8.44
Previous Close	8.15
Day's Range	7.50 - 8.44
52-Week Range	3.13 - 8.87
Beta	0.52
RSI	78.10
Earnings Date	Aug 25, 2025

About SHE:300158

Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally. It offers drugs for various fields, including cancer, cardiovascular, infectious disease, antibiotics, cardiocerebrovascular, antitumor, gastrointestinal, and respiratory, as well as urinary, tonic, dermatology, blood hematopoietic, digestion, urology, and heart and brain; vitamins; Chinese medicines in the form of pills, tablets, capsules, powders, and granu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 3,720
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300158

Financial Performance

In 2024, SHE:300158's revenue was 2.97 billion, a decrease of -18.06% compared to the previous year's 3.63 billion. Losses were -1.33 billion, 2920.6% more than in 2023.